Emily Ray, MD, MPH, talks with Ian Maurer, MS, about the potential advantages and limitations of using AI in oncology and in the clinic.
▷ Estimated Read Time:
1–2 minutes
SABCS Snippets: Artificial intelligence in the clinic
Join the global breast cancer community for four days of research spanning experimental biology, etiology, translational science, prevention, diagnosis and treatment, December 8-11 in San Antonio, Texas.
Share: